Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04786171 · ClinicalTrials.gov registry record
4D Medical X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 17
- Enrollment target
NCT04786171: Completed study, sponsored by Vanderbilt University Medical Center.
NCT04786171 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04786171 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This study will investigate the utility of 4D Medical's X-ray Velocimetry (XV) imaging analysis software for the detection of hyperinflation, and compare endobronchial valve placement outcomes with predictive indices obtained utilizing this technique.
Primary Outcome
We will compare an XV hyperinflation index to traditional pulmonary function tests (PFTs) and outcomes
Interventions
- DIAGNOSTIC_TEST 4D X-ray Velocimetry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-01-07 |
| Est. Completion | 2024-05-30 |
What the finished NCT04786171 record still lists
NCT04786171 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 4D X-ray Velocimetry is the first listed.
NCT04786171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04786171 about?
NCT04786171 is a clinical study titled "4D Medical X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting". This study will investigate the utility of 4D Medical's X-ray Velocimetry (XV) imaging analysis software for the detection of hyperinflation, and compare endobronchial valve placement outcomes with predictive indices obtained utilizing this technique.
What is the current status of trial NCT04786171?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2021-01-07. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT04786171?
The interventions under investigation include: 4D X-ray Velocimetry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04786171?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI